Genetic risk of thrombophilia (extended)

Hereditary thrombophilia is a disease most often caused by the carriage of unfavorable markers in the genes of blood coagulation factors and homocysteine regulation. An increased risk of developing hereditary thrombophilia should be suspected in the presence of a burdened family and personal history (deep vein thrombosis or severe form of varicose veins under the age of 50 in the patient and/or their relatives). The analysis includes a molecular genetic study of a complex of blood coagulation factors and homocysteine metabolism regulation, allowing the assessment of the individual genetic risk of developing venous and arterial thromboembolism. It is important to know that the disease, in the presence of hereditary predisposition, can be prevented by timely preventive and therapeutic measures.

Investigated genetic markers: F2 (G20210A), F5 (G1691A), F7 (G10976A), F13A1 (G103T), FGB (G(-455)A), ITGB3 (T1565C), SERPINE1 (5G(-675)4G), MTHFR (C677T), MTHFR (A1298C), ITGA2 (C807T).

The examination results are provided with an interpretation by a geneticist.

Within 5 days. The specified time does not include the day of biomaterial collection